AbbVie, Pfizer’s JAK inhibitors get FDA clearance to treat atopic dermatitis by Editor | Jan 17, 2022 | Government, Regulatory & Policy News, Hospitals, LATEST NEWS, WORLD NEWS | 0 USA – The FDA has approved two once-daily, oral JAK inhibitors on for patients with... Read More
New warnings added to the labels of arthritis medications amid JAK medications safety reviews by Editor | Dec 7, 2021 | Government, Regulatory & Policy News, Hospitals, LATEST NEWS, WORLD NEWS | 0 USA – The Food and Drug Administration (FDA) has added strictest warnings to the labels of... Read More